These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9805022

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blood recipients and CJD: to notify or not to notify, that is the question.
    Sibbald B.
    CMAJ; 1998 Oct 06; 159(7):829-31. PubMed ID: 9805032
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Canadian hospital-based HIV/hepatitis C look-back notification program.
    Heddle N, Kelton JG, Smaill F, Foss K, Everson J, Janzen C, Walker C, Jones M, Hammons D.
    CMAJ; 1997 Jul 15; 157(2):149-54. PubMed ID: 9238143
    [Abstract] [Full Text] [Related]

  • 8. Disclosure of medical error to parents and paediatric patients: assessment of parents' attitudes and influencing factors.
    Matlow AG, Moody L, Laxer R, Stevens P, Goia C, Friedman JN.
    Arch Dis Child; 2010 Apr 15; 95(4):286-90. PubMed ID: 19948514
    [Abstract] [Full Text] [Related]

  • 9. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML, Ludlam CA.
    Br J Haematol; 2009 Jan 15; 144(1):14-23. PubMed ID: 18950452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blood recipient notification for hepatitis C in Prince Edward Island.
    Van Til LD, Sweet LE.
    CMAJ; 2000 Jan 25; 162(2):199-202. PubMed ID: 10674052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Creutzfeld-Jakob disease: the Grace General Hospital experience.
    Pauls F, Hayes J, Read J.
    Leadersh Health Serv; 1996 Jan 25; 5(6):42-3. PubMed ID: 10163983
    [Abstract] [Full Text] [Related]

  • 14. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW, Head MW.
    Haemophilia; 2004 Oct 25; 10 Suppl 4():64-9. PubMed ID: 15479374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D.
    J Clin Ethics; 2001 Oct 25; 12(2):134-40. PubMed ID: 11642064
    [No Abstract] [Full Text] [Related]

  • 17. Factors associated with disclosure of diagnosis to children with HIV/AIDS.
    Wiener LS, Battles HB, Heilman N, Sigelman CK, Pizzo PA.
    Pediatr AIDS HIV Infect; 1996 Oct 25; 7(5):310-24. PubMed ID: 11361489
    [Abstract] [Full Text] [Related]

  • 18. Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives.
    Vamvakas EC.
    J Clin Apher; 1999 Oct 25; 14(3):135-43. PubMed ID: 10540369
    [Abstract] [Full Text] [Related]

  • 19. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan 25; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.